Yes, many people are on Dolutegravir as part of their HIV treatment regimen. Dolutegravir, known by the abbreviation DTG, is an antiviral medication of the integrase strand transfer inhibitor (INSTI) class. It's used in various combination therapies, including Dovato (Dolutegravir/Lamivudine), Tivicay (Dolutegravir alone... read more

Yes, many people are on Dolutegravir as part of their HIV treatment regimen. Dolutegravir, known by the abbreviation DTG, is an antiviral medication of the integrase strand transfer inhibitor (INSTI) class. It's used in various combination therapies, including Dovato (Dolutegravir/Lamivudine), Tivicay (Dolutegravir alone), and Triumeq (Abacavir/Dolutegravir/Lamivudine). People generally do well on Dolutegravir-based treatments, but like any medication, it can have side effects. Common side effects include headache, insomnia, and fatigue. It's important to discuss any concerns or side effects with a healthcare provider to ensure the best possible outcome with this treatment.

 This AI-generated response comes from myHIVteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Tivicay (Dolutegravir) for HIV | myHIVteam

Triumeq (Abacavir/Dolutegravir/Lamivudine) for HIV | myHIVteam